A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.
Scientists have long believed that a newborn’s immune system was an immature version of an adult’s, but new research shows that newborns’ T cells – white blood cells that protect from disease – outperform those of adults at fighting off numerous infections.
Faculty, staff and community partners are working together to address community needs — and they’re getting students involved with support from Engaged Opportunity Grants from the Einhorn Center for Community Engagement.
Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.
Open to the entire Cornell community, the meditation program serves to counter the rigor of classes and work, offering participants a moment to breathe and reflect via sessions offered both in-person and virtually.
Door-to-door surveillance surveys can provide more precise estimates of how many people are infected with COVID-19 or have immunity to COVID-19 at any given point in time than relying on self-reporting and self-testing, a Cornell-led research group has found.
Two faculty members – one studying killer fungi and the other using yeast to find safer painkillers – are winners of Schwartz grants, given annually to female faculty or faculty who enhance the diversity, equity and inclusion goals of the university.
An experimental mRNA vaccine against human cytomegalovirus, a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any vaccine candidate, according to a study by Weill Cornell Medicine investigators.
